The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
Autor: | King, Erin R., Zu, Zhifei, Tsang, Yvonne T.M., Deavers, Michael T., Malpica, Anais, Mok, Samuel C., Gershenson, David M., Wong, Kwong-Kwok |
---|---|
Zdroj: | In Gynecologic Oncology 2011 123(1):13-18 |
Databáze: | ScienceDirect |
Externí odkaz: |